These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34585275)

  • 21. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients.
    Jorde UP; Uriel N; Nahumi N; Bejar D; Gonzalez-Costello J; Thomas SS; Han J; Morrison KA; Jones S; Kodali S; Hahn RT; Shames S; Yuzefpolskaya M; Colombo P; Takayama H; Naka Y
    Circ Heart Fail; 2014 Mar; 7(2):310-9. PubMed ID: 24415682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics.
    Parikh KS; Mehrotra AK; Russo MJ; Lang RM; Anderson A; Jeevanandam V; Freed BH; Paul JD; Karol J; Nathan S; Shah AP
    JACC Cardiovasc Interv; 2013 Jan; 6(1):84-9. PubMed ID: 23347865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency.
    Retzer EM; Sayer GT; Fedson SE; Nathan S; Jeevanandam V; Friant J; Uriel N; Lang RM; Russo MJ; Shah AP
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):971-9. PubMed ID: 26527571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device.
    Hatano M; Kinugawa K; Shiga T; Kato N; Endo M; Hisagi M; Nishimura T; Yao A; Hirata Y; Kyo S; Ono M; Nagai R
    Circ J; 2011; 75(5):1147-55. PubMed ID: 21378448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device.
    Dobarro D; Urban M; Booth K; Wrightson N; Castrodeza J; Jungschleger J; Robinson-Smith N; Woods A; Parry G; Schueler S; MacGowan GA
    J Heart Lung Transplant; 2017 Jan; 36(1):42-49. PubMed ID: 27776988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aortic insufficiency in patients with sustained left ventricular systolic dysfunction after axial flow assist device implantation.
    Imamura T; Kinugawa K; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Ono M
    Circ J; 2015; 79(1):104-11. PubMed ID: 25381791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant aortic valve repair with continuous-flow left ventricular assist devices: Results and implications.
    Fukuhara S; Takeda K; Chiuzan C; Han J; Polanco AR; Yuzefpolskaya M; Mancini DM; Colombo PC; Topkara VK; Kurlansky PA; Takayama H; Naka Y
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):201-9, 210.e1-2. PubMed ID: 26699773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of uncorrected mild aortic insufficiency at the time of left ventricular assist device implantation.
    Tanaka Y; Nakajima T; Fischer I; Wan F; Kotkar K; Moon MR; Damiano RJ; Masood MF; Itoh A
    J Thorac Cardiovasc Surg; 2020 Dec; 160(6):1490-1500.e3. PubMed ID: 32998831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of de novo aortic valve incompetence in patients with the continuous-flow HeartWare ventricular assist device.
    Bhagra S; Bhagra C; Özalp F; Butt T; Ramesh BC; Parry G; Roysam C; Woods A; Robinson-Smith N; Wrightson N; MacGowan GA; Schueler S
    J Heart Lung Transplant; 2016 Mar; 35(3):312-319. PubMed ID: 26612054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of aortic insufficiency in left ventricular assist device-supported patients.
    Cowger J; Pagani FD; Haft JW; Romano MA; Aaronson KD; Kolias TJ
    Circ Heart Fail; 2010 Nov; 3(6):668-74. PubMed ID: 20739615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of aortic insufficiency in continuous-flow left ventricular assist device-supported patients.
    Aggarwal A; Raghuvir R; Eryazici P; Macaluso G; Sharma P; Blair C; Tatooles AJ; Pappas PS; Bhat G
    Ann Thorac Surg; 2013 Feb; 95(2):493-8. PubMed ID: 23245444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aortic Insufficiency During Contemporary Left Ventricular Assist Device Support: Analysis of the INTERMACS Registry.
    Truby LK; Garan AR; Givens RC; Wayda B; Takeda K; Yuzefpolskaya M; Colombo PC; Naka Y; Takayama H; Topkara VK
    JACC Heart Fail; 2018 Nov; 6(11):951-960. PubMed ID: 30384913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accurate Quantification Methods for Aortic Insufficiency Severity in Patients With LVAD: Role of Diastolic Flow Acceleration and Systolic-to-Diastolic Peak Velocity Ratio of Outflow Cannula.
    Grinstein J; Kruse E; Sayer G; Fedson S; Kim GH; Jorde UP; Juricek C; Ota T; Jeevanandam V; Lang RM; Uriel N
    JACC Cardiovasc Imaging; 2016 Jun; 9(6):641-51. PubMed ID: 26684975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous-Flow Left Ventricular Assist Devices and the Aortic Valve: Interactions, Issues, and Surgical Therapy.
    Goodwin ML; Bobba CM; Mokadam NA; Whitson BA; Essandoh M; Hasan A; Ganapathi AM
    Curr Heart Fail Rep; 2020 Aug; 17(4):97-105. PubMed ID: 32488504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aortic insufficiency associated with Impella that required surgical intervention upon implantation of the durable left ventricular assist device.
    Oishi H; Kondo T; Fujimoto K; Mutsuga M; Morimoto R; Hirano KI; Sawamura A; Kazama S; Kimura Y; Shibata N; Kato H; Arao Y; Kuwayama T; Yamaguchi S; Hiraiwa H; Okumura T; Usui A; Murohara T
    J Artif Organs; 2020 Dec; 23(4):378-382. PubMed ID: 32562105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of aortic valve insufficiency during centrifugal versus axial flow left ventricular assist device support.
    Jimenez Contreras F; Mendiola Pla M; Schroder J; Bryner B; Agarwal R; Russell SD; Mirza J; Daneshmand MA; Milano C
    Eur J Cardiothorac Surg; 2022 May; 61(5):1188-1196. PubMed ID: 35167677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of aortic valvuloplasty for de novo aortic insufficiency in patients with a left-ventricular assist device.
    Tadokoro N; Kainuma S; Kawamoto N; Kakuta T; Tonai K; Shimizu H; Fujita T; Fukushima S
    Gen Thorac Cardiovasc Surg; 2024 May; 72(5):324-330. PubMed ID: 37709989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accurate Method of Quantification of Aortic Insufficiency During Left Ventricular Assist Device Support by Thermodilution Analysis: Proof of Concept and Validation by a Mock Circulatory System.
    Akiyama D; Nishimura T; Sumikura H; Iizuka K; Mizuno T; Tsukiya T; Takewa Y; Ono M; Tatsumi E
    Artif Organs; 2018 Oct; 42(10):954-960. PubMed ID: 30062741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of aortic insufficiency during long-term axial continuous-flow left ventricular assist device support.
    Cowger JA; Aaronson KD; Romano MA; Haft J; Pagani FD
    J Heart Lung Transplant; 2014 Dec; 33(12):1233-40. PubMed ID: 25108909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors and Long-Term Impact of De Novo Aortic Regurgitation in Continuous Flow Left Ventricular Assist Devices Using Vena Contracta.
    Park JR; Brady PA; Clavell AL; Maleszewski JJ; Nkomo VT; Pislaru SV; Stulak JM; Lin G
    ASAIO J; 2022 May; 68(5):691-697. PubMed ID: 34506330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.